As was promised at the start of 2025, Alnylam Pharmaceuticals Inc. has become a profitable company following the approval of its rare heart-disease drug.

Major institutions have backed it with billions since early 2025. The company employs over 120 people locally.

U.S. stocks are ticking higher and once again flirting with a record following mixed profit reports from big companies. The S ...

The increased payment to shareholders came as Brookfield reported net income attributable to shareholders of US$743-million ...

TC Energy’s adjusted core profit at U.S. natural gas pipelines, its largest segment, rose to $1.39-billion, from $1.2-billion ...

German carmaker Mercedes-Benz reported Thursday its lowest annual profit since the Covid pandemic, as it counted the cost of ...

British pharmaceutical giant AstraZeneca said Tuesday that its net profit jumped 45 percent last year on strong sales of ...

Good Law Project claims U.K. health secretary Wes Streeting's department fought to block freedom of information requests for ...

Before making any decisions, it's important to gain a clear understanding of how the different family-building paths work.

In a presentation to investors, the company said it expects to open up to 175 new U.S. coffee shops this year and about 400 ...

Specialised gangs piloting drones to fly drugs and weapons into prisons are working up and down the country to "beat" the system, the governor of HMP Manchester has told Sky News.

Parts of the aviation industry are shifting towards wealthy customers and selling a more luxurious type of international ...